The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
![]() ![]() | Gucciardo, F.* , Lebeau, A.* , Pirson, S.* , Buntinx, F.* , Ivanova, E.* , Blacher, S., Brouillard, P., Deroye, J., Baudin, L., Pirnay, A., Morfoisse, F., Villette, C., Nizet, C., Lallemand, F., Munaut, C., Alitalo, K., Geris, L., Vikkula, M., Gautier-Isola, M.* , & Noël, A.*. (13 May 2025). Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema. Circulation, 151, 1412-1429. doi:10.1161/CIRCULATIONAHA.124.072093 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Dupont, L.* , Noël, A.* , Colige, A.* , Joannes, L. (Other coll.), Morfoisse, F. (Other coll.), BLACHER, S. (Other coll.), Monseur, C. (Other coll.), & Deroanne, C. (Other coll.). (2022). ADAMTS2 and ADAMTS14 substitute ADAMTS3 in adults for proVEGFC activation and lymphatic homeostasis. JCI Insight. doi:10.1172/jci.insight.151509 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Bekisz, S., Morfoisse, F., Noël, A., & Geris, L. (27 November 2019). Computational and mathematical lymphangiogenesis : Development of an intracellular network model in lymphatic endothelial cells [Poster presentation]. NCBME. ![]() |
![]() ![]() | Bekisz, S., Morfoisse, F., Noël, A., & Geris, L. (May 2019). In silico lymphangiogenesis : Development of new tools to generate novel insights in the fundamental mechanisms regulating lymphangiogenesis [Poster presentation]. Conference SBHD 2019, Berlin, Germany. ![]() |
![]() ![]() | Morfoisse, F., & Noël, A. (2019). Lymphatic and blood systems: Identical or fraternal twins? International Journal of Biochemistry and Cell Biology, 114, 105562. doi:10.1016/j.biocel.2019.105562 ![]() |
![]() ![]() | Morfoisse, F.* , Tatin, F.* , Chaput, B., Therville, N., Vaysse, C., Métivier, R., Malloizel-Delaunay, J., Pujol, F., Godet, A.-C., De Toni, F., Boudou, F., Grenier, K., Dubuc, D., Lacazette, E., Prats, A.-C., Guillermet-Guibert, J., Lenfant, F., & Garmy-susini, B. (2018). Lymphatic Vasculature Requires Estrogen Receptor-α Signaling to Protect From Lymphedema. Arteriosclerosis, Thrombosis and Vascular Biology. doi:10.1161/ATVBAHA.118.310997 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Durré, T., Morfoisse, F., ERPICUM, C., Ebroin, M., Blacher, S., García Caballero, M., Deroanne, C., Louis, T., BALSAT, C., Van De Velde, M., Kaijalainen, S., Kridelka, F., Engelholm, L., Struman, I., Alitalo, K., Behrendt, N., Paupert, J., & Noël, A. (2018). uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nature Communications, 9 (1), 5178. doi:10.1038/s41467-018-07514-1 ![]() |
Morfoisse, F., Durré, T., ERPICUM, C., Ebroin, M., Blacher, S., Garcia-caballero, M., Deroanne, C., Behrendt, N., Paupert, J., & Noël, A. (08 June 2017). uPARAP/endo180 receptor acts as a gatekeeper of pathological lymphangiogenesis by controlling VEGF-C driven lymphatic endothelial cell migration [Poster presentation]. Lymphatic Forum 2017, Chicago, United States - Illinois. |
Morfoisse, F. (24 April 2017). Lymphatic vasculature requires estrogen receptor alpha signaling to protect from lymphedema [Paper presentation]. 7ème Congrès de la Société Française d'Angiogenèse, toulouse, France. |
![]() ![]() | Morfoisse, F., Tatin, F., Hantelys, F., Adoue, A., Helfer, A.-C., Cassant-Sourdy, S., Pujol, F., Gomez-Brouchet, A., Ligat, L., Lopez, F., Pyronnet, S., Courty, J., Guillermet-Guibert, J., Marzi, S., Schneider, R. J., Prats, A.-C., & Garmy-Susini, B. H. (01 August 2016). Nucleolin Promotes Heat Shock-Associated Translation of VEGF-D to Promote Tumor Lymphangiogenesis. Cancer Research, 76 (15), 4394-405. doi:10.1158/0008-5472.CAN-15-3140 ![]() |
![]() ![]() | Morfoisse, F., Tatin, F., Lenfant, F., Prats, A.-C., & Garmy-susini, B. (26 June 2015). Beneficial effect of estrogen on lymphatic system is inhibited by hormone therapy to promote lymphedema [Poster presentation]. 11e congrès de la Nouvelle Société Française d'Athérosclerose, Biarritz, France. |
![]() ![]() | Morfoisse, F., Tatin, F., Lenfant, F., Prats, A.-C., & Garmy-susini, B. (20 January 2015). Tamoxifen induces lymphatic vessels disruption and promotes lymphedema [Poster presentation]. Gordon Research Conference for Vascular Biology, Ventura, United States - California. |
![]() ![]() | Renaud-Gabardos, E., Hantelys, F., Morfoisse, F., Chaufour, X., Garmy-Susini, B., & Prats, A.-C. (2015). Internal ribosome entry site-based vectors for combined gene therapy. World journal of experimental medicine, 5 (1), 11-20. doi:10.5493/wjem.v5.i1.11 ![]() |
![]() ![]() | Morfoisse, F. (17 October 2014). L'hypoxie induit l'expression du VEGF-C dans les loci métastatiques via un mécanisme traductionnel [Paper presentation]. 10e journées du Canceropôle Grand Sud Ouest, Toulouse, France. |
![]() ![]() | Morfoisse, F., Kuchnio, A., Frainay, C., Gomez-Brouchet, A., Delisle, M.-B., Marzi, S., Helfer, A.-C., Hantelys, F., Pujol, F., Guillermet-Guibert, J., Bousquet, C., Dewerchin, M., Pyronnet, S., Prats, A.-C., Carmeliet, P., & Garmy-susini, B. (16 January 2014). Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1a-Independent Translation-Mediated Mechanism. Cell Reports, 6, 155-167. ![]() |
![]() ![]() | Morfoisse, F., Renaud, E., Hantelys, F., Prats, A.-C., & Garmy-Susini, B. (2014). Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis. Molecular and Cellular Oncology, 1 (1), 29907. doi:10.4161/mco.29907 ![]() |
![]() ![]() | Morfoisse, F., Renaud, E., Hantelys, F., Prats, A.-C., & Garmy-Susini, B. (2014). Adaptation de la synthese proteique du VEGF-C par les cellules tumorales en condition hypoxique. MS. Medecine Sciences, 30 (5), 506-8. doi:10.1051/medsci/20143005010 ![]() |
![]() ![]() | Prats, A. C., Van den Berghe, L., Rayssac, A., Ainaoui, N., Morfoisse, F., Pujol, F., Legonidec, S., Bikfalvi, A., Prats, H., Pyronnet, S., & Garmy-Susini, B. (2013). CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis. Microvascular Research, 89, 25-33. doi:10.1016/j.mvr.2013.05.005 ![]() |
![]() ![]() | Morfoisse, F., Frainay, C., Pujol, F., Bousquet, C., Pyronnet, S., Prats, A.-C., & Garmy-susini, B. (29 October 2012). Hypoxia induces translational regulation of VEGFC [Poster presentation]. 4e congrès de la Société Française d'Angiogenèse, Monte Carlo, Monaco. |